nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—PTPRS—female reproductive system—ovarian cancer	0.0297	0.0791	CbGeAlD
Etidronic acid—ATP6V1A—myometrium—ovarian cancer	0.0294	0.0782	CbGeAlD
Etidronic acid—ATP6V1A—embryo—ovarian cancer	0.0282	0.0752	CbGeAlD
Etidronic acid—PTPRS—bone marrow—ovarian cancer	0.028	0.0747	CbGeAlD
Etidronic acid—PTPRS—female gonad—ovarian cancer	0.027	0.072	CbGeAlD
Etidronic acid—Leukaemia—Melphalan—ovarian cancer	0.0246	0.0475	CcSEcCtD
Etidronic acid—PTPRS—testis—ovarian cancer	0.024	0.0638	CbGeAlD
Etidronic acid—ATP6V1A—uterine cervix—ovarian cancer	0.0229	0.0609	CbGeAlD
Etidronic acid—PTPRS—ECM proteoglycans—ITGA8—ovarian cancer	0.0225	0.212	CbGpPWpGaD
Etidronic acid—ATP6V1A—decidua—ovarian cancer	0.0218	0.058	CbGeAlD
Etidronic acid—ATP6V1A—endometrium—ovarian cancer	0.0207	0.0551	CbGeAlD
Etidronic acid—ATP6V1A—gonad—ovarian cancer	0.0192	0.0511	CbGeAlD
Etidronic acid—ATP6V1A—uterus—ovarian cancer	0.019	0.0507	CbGeAlD
Etidronic acid—PTPRS—lymph node—ovarian cancer	0.0174	0.0463	CbGeAlD
Etidronic acid—ATP6V1A—female reproductive system—ovarian cancer	0.0171	0.0456	CbGeAlD
Etidronic acid—ATP6V1A—bone marrow—ovarian cancer	0.0162	0.0431	CbGeAlD
Etidronic acid—ATP6V1A—female gonad—ovarian cancer	0.0156	0.0415	CbGeAlD
Etidronic acid—ATP6V1A—vagina—ovarian cancer	0.0155	0.0413	CbGeAlD
Etidronic acid—PTPRS—ECM proteoglycans—SPARC—ovarian cancer	0.0145	0.137	CbGpPWpGaD
Etidronic acid—ATP6V1A—testis—ovarian cancer	0.0138	0.0368	CbGeAlD
Etidronic acid—Pancytopenia—Altretamine—ovarian cancer	0.0127	0.0246	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Altretamine—ovarian cancer	0.0117	0.0226	CcSEcCtD
Etidronic acid—Glossodynia—Paclitaxel—ovarian cancer	0.0117	0.0225	CcSEcCtD
Etidronic acid—ATP6V1A—lymph node—ovarian cancer	0.01	0.0267	CbGeAlD
Etidronic acid—Rash macular—Paclitaxel—ovarian cancer	0.00949	0.0183	CcSEcCtD
Etidronic acid—Anaemia—Altretamine—ovarian cancer	0.00864	0.0167	CcSEcCtD
Etidronic acid—Leukopenia—Altretamine—ovarian cancer	0.00837	0.0161	CcSEcCtD
Etidronic acid—Leukaemia—Epirubicin—ovarian cancer	0.00826	0.0159	CcSEcCtD
Etidronic acid—Leukaemia—Doxorubicin—ovarian cancer	0.00765	0.0148	CcSEcCtD
Etidronic acid—Bone pain—Topotecan—ovarian cancer	0.00706	0.0136	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—DOK1—ovarian cancer	0.0068	0.0639	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—ITGA8—ovarian cancer	0.00643	0.0605	CbGpPWpGaD
Etidronic acid—Rash maculo-papular—Topotecan—ovarian cancer	0.00615	0.0119	CcSEcCtD
Etidronic acid—Oesophagitis—Vinorelbine—ovarian cancer	0.00529	0.0102	CcSEcCtD
Etidronic acid—Infection—Carboplatin—ovarian cancer	0.00524	0.0101	CcSEcCtD
Etidronic acid—Vomiting—Altretamine—ovarian cancer	0.00485	0.00936	CcSEcCtD
Etidronic acid—Nausea—Altretamine—ovarian cancer	0.00453	0.00874	CcSEcCtD
Etidronic acid—Pancytopenia—Chlorambucil—ovarian cancer	0.00453	0.00874	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00421	0.00813	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00417	0.00804	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—SPARC—ovarian cancer	0.00414	0.039	CbGpPWpGaD
Etidronic acid—Bone pain—Paclitaxel—ovarian cancer	0.00406	0.00784	CcSEcCtD
Etidronic acid—Pancytopenia—Topotecan—ovarian cancer	0.00403	0.00778	CcSEcCtD
Etidronic acid—Pancytopenia—Melphalan—ovarian cancer	0.00395	0.00762	CcSEcCtD
Etidronic acid—Hallucination—Chlorambucil—ovarian cancer	0.0038	0.00733	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Topotecan—ovarian cancer	0.00371	0.00716	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Melphalan—ovarian cancer	0.00363	0.00701	CcSEcCtD
Etidronic acid—Erythema multiforme—Chlorambucil—ovarian cancer	0.00361	0.00696	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Paclitaxel—ovarian cancer	0.00358	0.0069	CcSEcCtD
Etidronic acid—Oesophagitis—Paclitaxel—ovarian cancer	0.00356	0.00686	CcSEcCtD
Etidronic acid—Rash maculo-papular—Paclitaxel—ovarian cancer	0.00354	0.00683	CcSEcCtD
Etidronic acid—Pancytopenia—Vinorelbine—ovarian cancer	0.00345	0.00665	CcSEcCtD
Etidronic acid—Bone pain—Docetaxel—ovarian cancer	0.00344	0.00665	CcSEcCtD
Etidronic acid—Alopecia—Chlorambucil—ovarian cancer	0.00337	0.00651	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00317	0.00612	CcSEcCtD
Etidronic acid—Anaemia—Chlorambucil—ovarian cancer	0.00307	0.00592	CcSEcCtD
Etidronic acid—Angioedema—Chlorambucil—ovarian cancer	0.00304	0.00586	CcSEcCtD
Etidronic acid—Agranulocytosis—Vinorelbine—ovarian cancer	0.00302	0.00583	CcSEcCtD
Etidronic acid—Oesophagitis—Docetaxel—ovarian cancer	0.00301	0.00582	CcSEcCtD
Etidronic acid—Alopecia—Topotecan—ovarian cancer	0.003	0.00579	CcSEcCtD
Etidronic acid—Leukopenia—Chlorambucil—ovarian cancer	0.00297	0.00574	CcSEcCtD
Etidronic acid—Alopecia—Melphalan—ovarian cancer	0.00294	0.00567	CcSEcCtD
Etidronic acid—Muscle spasms—Topotecan—ovarian cancer	0.00284	0.00549	CcSEcCtD
Etidronic acid—Confusional state—Chlorambucil—ovarian cancer	0.00273	0.00527	CcSEcCtD
Etidronic acid—Anaemia—Topotecan—ovarian cancer	0.00273	0.00527	CcSEcCtD
Etidronic acid—Angioedema—Topotecan—ovarian cancer	0.0027	0.00521	CcSEcCtD
Etidronic acid—Infection—Chlorambucil—ovarian cancer	0.00269	0.0052	CcSEcCtD
Etidronic acid—Anaemia—Melphalan—ovarian cancer	0.00268	0.00516	CcSEcCtD
Etidronic acid—Leukopenia—Topotecan—ovarian cancer	0.00265	0.00511	CcSEcCtD
Etidronic acid—Leukopenia—Melphalan—ovarian cancer	0.00259	0.005	CcSEcCtD
Etidronic acid—Alopecia—Vinorelbine—ovarian cancer	0.00257	0.00496	CcSEcCtD
Etidronic acid—Erythema—Vinorelbine—ovarian cancer	0.00253	0.00488	CcSEcCtD
Etidronic acid—Arthralgia—Topotecan—ovarian cancer	0.00252	0.00486	CcSEcCtD
Etidronic acid—Discomfort—Topotecan—ovarian cancer	0.00249	0.0048	CcSEcCtD
Etidronic acid—Arthropathy—Epirubicin—ovarian cancer	0.00245	0.00472	CcSEcCtD
Etidronic acid—Glossitis—Epirubicin—ovarian cancer	0.00241	0.00466	CcSEcCtD
Etidronic acid—Infection—Topotecan—ovarian cancer	0.0024	0.00463	CcSEcCtD
Etidronic acid—Dyspepsia—Chlorambucil—ovarian cancer	0.00239	0.0046	CcSEcCtD
Etidronic acid—Infection—Melphalan—ovarian cancer	0.00235	0.00453	CcSEcCtD
Etidronic acid—Anaemia—Vinorelbine—ovarian cancer	0.00234	0.00451	CcSEcCtD
Etidronic acid—Bone pain—Epirubicin—ovarian cancer	0.00232	0.00448	CcSEcCtD
Etidronic acid—Pancytopenia—Paclitaxel—ovarian cancer	0.00232	0.00447	CcSEcCtD
Etidronic acid—Angioedema—Vinorelbine—ovarian cancer	0.00231	0.00446	CcSEcCtD
Etidronic acid—Leukopenia—Vinorelbine—ovarian cancer	0.00226	0.00437	CcSEcCtD
Etidronic acid—Arthropathy—Doxorubicin—ovarian cancer	0.00226	0.00437	CcSEcCtD
Etidronic acid—Glossitis—Doxorubicin—ovarian cancer	0.00223	0.00431	CcSEcCtD
Etidronic acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.00223	0.00431	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00222	0.00428	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.0022	0.00424	CcSEcCtD
Etidronic acid—Paraesthesia—Topotecan—ovarian cancer	0.00217	0.00418	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00216	0.00417	CcSEcCtD
Etidronic acid—Urticaria—Chlorambucil—ovarian cancer	0.00215	0.00416	CcSEcCtD
Etidronic acid—Arthralgia—Vinorelbine—ovarian cancer	0.00215	0.00416	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00215	0.00415	CcSEcCtD
Etidronic acid—Bone pain—Doxorubicin—ovarian cancer	0.00215	0.00415	CcSEcCtD
Etidronic acid—Abdominal pain—Chlorambucil—ovarian cancer	0.00214	0.00414	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00213	0.00412	CcSEcCtD
Etidronic acid—Discomfort—Vinorelbine—ovarian cancer	0.00213	0.00411	CcSEcCtD
Etidronic acid—Dyspepsia—Topotecan—ovarian cancer	0.00212	0.0041	CcSEcCtD
Etidronic acid—Paraesthesia—Melphalan—ovarian cancer	0.00212	0.00409	CcSEcCtD
Etidronic acid—Dyspepsia—Melphalan—ovarian cancer	0.00208	0.00401	CcSEcCtD
Etidronic acid—Constipation—Topotecan—ovarian cancer	0.00206	0.00398	CcSEcCtD
Etidronic acid—Infection—Vinorelbine—ovarian cancer	0.00205	0.00396	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Epirubicin—ovarian cancer	0.00204	0.00394	CcSEcCtD
Etidronic acid—Oesophagitis—Epirubicin—ovarian cancer	0.00203	0.00392	CcSEcCtD
Etidronic acid—Rash maculo-papular—Epirubicin—ovarian cancer	0.00202	0.0039	CcSEcCtD
Etidronic acid—Hypersensitivity—Chlorambucil—ovarian cancer	0.002	0.00385	CcSEcCtD
Etidronic acid—Feeling abnormal—Topotecan—ovarian cancer	0.00199	0.00384	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Topotecan—ovarian cancer	0.00197	0.00381	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6ST—ovarian cancer	0.00197	0.0185	CbGpPWpGaD
Etidronic acid—Pancytopenia—Docetaxel—ovarian cancer	0.00197	0.00379	CcSEcCtD
Etidronic acid—Pruritus—Chlorambucil—ovarian cancer	0.00192	0.0037	CcSEcCtD
Etidronic acid—Urticaria—Topotecan—ovarian cancer	0.00192	0.0037	CcSEcCtD
Etidronic acid—Abdominal pain—Topotecan—ovarian cancer	0.00191	0.00368	CcSEcCtD
Etidronic acid—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.00189	0.00365	CcSEcCtD
Etidronic acid—Oesophagitis—Doxorubicin—ovarian cancer	0.00188	0.00363	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00188	0.00363	CcSEcCtD
Etidronic acid—Urticaria—Melphalan—ovarian cancer	0.00188	0.00362	CcSEcCtD
Etidronic acid—Rash maculo-papular—Doxorubicin—ovarian cancer	0.00187	0.00361	CcSEcCtD
Etidronic acid—Diarrhoea—Chlorambucil—ovarian cancer	0.00186	0.00358	CcSEcCtD
Etidronic acid—Paraesthesia—Vinorelbine—ovarian cancer	0.00185	0.00358	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HSD17B6—ovarian cancer	0.00185	0.0174	CbGpPWpGaD
Etidronic acid—Erythema multiforme—Paclitaxel—ovarian cancer	0.00185	0.00357	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CDH1—ovarian cancer	0.00184	0.0173	CbGpPWpGaD
Etidronic acid—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00183	0.00353	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00181	0.017	CbGpPWpGaD
Etidronic acid—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00181	0.00349	CcSEcCtD
Etidronic acid—Hypersensitivity—Topotecan—ovarian cancer	0.00178	0.00343	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP2—ovarian cancer	0.00178	0.0167	CbGpPWpGaD
Etidronic acid—Constipation—Vinorelbine—ovarian cancer	0.00177	0.00341	CcSEcCtD
Etidronic acid—Hypersensitivity—Melphalan—ovarian cancer	0.00174	0.00336	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00174	0.0163	CbGpPWpGaD
Etidronic acid—Alopecia—Paclitaxel—ovarian cancer	0.00173	0.00333	CcSEcCtD
Etidronic acid—Vomiting—Chlorambucil—ovarian cancer	0.00172	0.00333	CcSEcCtD
Etidronic acid—Agranulocytosis—Docetaxel—ovarian cancer	0.00172	0.00332	CcSEcCtD
Etidronic acid—Pruritus—Topotecan—ovarian cancer	0.00171	0.00329	CcSEcCtD
Etidronic acid—Erythema—Paclitaxel—ovarian cancer	0.0017	0.00328	CcSEcCtD
Etidronic acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.0017	0.00328	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00169	0.00326	CcSEcCtD
Etidronic acid—Flatulence—Paclitaxel—ovarian cancer	0.00168	0.00324	CcSEcCtD
Etidronic acid—Pruritus—Melphalan—ovarian cancer	0.00167	0.00323	CcSEcCtD
Etidronic acid—Diarrhoea—Topotecan—ovarian cancer	0.00165	0.00319	CcSEcCtD
Etidronic acid—Urticaria—Vinorelbine—ovarian cancer	0.00164	0.00316	CcSEcCtD
Etidronic acid—Muscle spasms—Paclitaxel—ovarian cancer	0.00164	0.00316	CcSEcCtD
Etidronic acid—Abdominal pain—Vinorelbine—ovarian cancer	0.00163	0.00315	CcSEcCtD
Etidronic acid—Diarrhoea—Melphalan—ovarian cancer	0.00162	0.00312	CcSEcCtD
Etidronic acid—Osteoarthritis—Epirubicin—ovarian cancer	0.00162	0.00312	CcSEcCtD
Etidronic acid—Nausea—Chlorambucil—ovarian cancer	0.00161	0.00311	CcSEcCtD
Etidronic acid—Anaemia—Paclitaxel—ovarian cancer	0.00157	0.00303	CcSEcCtD
Etidronic acid—Erythema multiforme—Docetaxel—ovarian cancer	0.00157	0.00302	CcSEcCtD
Etidronic acid—Angioedema—Paclitaxel—ovarian cancer	0.00155	0.003	CcSEcCtD
Etidronic acid—Vomiting—Topotecan—ovarian cancer	0.00153	0.00296	CcSEcCtD
Etidronic acid—Leukopenia—Paclitaxel—ovarian cancer	0.00152	0.00294	CcSEcCtD
Etidronic acid—Rash—Topotecan—ovarian cancer	0.00152	0.00294	CcSEcCtD
Etidronic acid—Hypersensitivity—Vinorelbine—ovarian cancer	0.00152	0.00294	CcSEcCtD
Etidronic acid—Dermatitis—Topotecan—ovarian cancer	0.00152	0.00293	CcSEcCtD
Etidronic acid—Headache—Topotecan—ovarian cancer	0.00151	0.00292	CcSEcCtD
Etidronic acid—Vomiting—Melphalan—ovarian cancer	0.0015	0.0029	CcSEcCtD
Etidronic acid—Osteoarthritis—Doxorubicin—ovarian cancer	0.00149	0.00288	CcSEcCtD
Etidronic acid—Rash—Melphalan—ovarian cancer	0.00149	0.00288	CcSEcCtD
Etidronic acid—Dermatitis—Melphalan—ovarian cancer	0.00149	0.00287	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CHMP4C—ovarian cancer	0.00148	0.0139	CbGpPWpGaD
Etidronic acid—Alopecia—Docetaxel—ovarian cancer	0.00146	0.00282	CcSEcCtD
Etidronic acid—Pruritus—Vinorelbine—ovarian cancer	0.00146	0.00282	CcSEcCtD
Etidronic acid—Arthralgia—Paclitaxel—ovarian cancer	0.00145	0.0028	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MTOR—ovarian cancer	0.00145	0.0136	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CB—ovarian cancer	0.00145	0.0136	CbGpPWpGaD
Etidronic acid—Erythema—Docetaxel—ovarian cancer	0.00144	0.00278	CcSEcCtD
Etidronic acid—Nausea—Topotecan—ovarian cancer	0.00143	0.00277	CcSEcCtD
Etidronic acid—Discomfort—Paclitaxel—ovarian cancer	0.00143	0.00276	CcSEcCtD
Etidronic acid—Gastritis—Epirubicin—ovarian cancer	0.00143	0.00276	CcSEcCtD
Etidronic acid—Diarrhoea—Vinorelbine—ovarian cancer	0.00141	0.00273	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—CASP3—ovarian cancer	0.00141	0.0133	CbGpPWpGaD
Etidronic acid—Nausea—Melphalan—ovarian cancer	0.0014	0.00271	CcSEcCtD
Etidronic acid—Confusional state—Paclitaxel—ovarian cancer	0.0014	0.0027	CcSEcCtD
Etidronic acid—Asthma—Epirubicin—ovarian cancer	0.0014	0.00269	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—ovarian cancer	0.00139	0.00268	CcSEcCtD
Etidronic acid—Infection—Paclitaxel—ovarian cancer	0.00138	0.00266	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00137	0.0129	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—MMP9—ovarian cancer	0.00134	0.0126	CbGpPWpGaD
Etidronic acid—Anaemia—Docetaxel—ovarian cancer	0.00133	0.00257	CcSEcCtD
Etidronic acid—Pancytopenia—Epirubicin—ovarian cancer	0.00133	0.00256	CcSEcCtD
Etidronic acid—Gastritis—Doxorubicin—ovarian cancer	0.00132	0.00255	CcSEcCtD
Etidronic acid—Vomiting—Vinorelbine—ovarian cancer	0.00131	0.00253	CcSEcCtD
Etidronic acid—Rash—Vinorelbine—ovarian cancer	0.0013	0.00251	CcSEcCtD
Etidronic acid—Dermatitis—Vinorelbine—ovarian cancer	0.0013	0.00251	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—HSD17B6—ovarian cancer	0.0013	0.0122	CbGpPWpGaD
Etidronic acid—Headache—Vinorelbine—ovarian cancer	0.00129	0.0025	CcSEcCtD
Etidronic acid—Asthma—Doxorubicin—ovarian cancer	0.00129	0.00249	CcSEcCtD
Etidronic acid—Leukopenia—Docetaxel—ovarian cancer	0.00129	0.00249	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—BCL9—ovarian cancer	0.00128	0.0121	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00127	0.00244	CcSEcCtD
Etidronic acid—Paraesthesia—Paclitaxel—ovarian cancer	0.00125	0.00241	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00123	0.00238	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—ovarian cancer	0.00123	0.00237	CcSEcCtD
Etidronic acid—Pancytopenia—Doxorubicin—ovarian cancer	0.00123	0.00237	CcSEcCtD
Etidronic acid—Nausea—Vinorelbine—ovarian cancer	0.00123	0.00237	CcSEcCtD
Etidronic acid—Dyspepsia—Paclitaxel—ovarian cancer	0.00122	0.00236	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00122	0.00235	CcSEcCtD
Etidronic acid—Constipation—Paclitaxel—ovarian cancer	0.00119	0.00229	CcSEcCtD
Etidronic acid—Confusional state—Docetaxel—ovarian cancer	0.00119	0.00229	CcSEcCtD
Etidronic acid—Infection—Docetaxel—ovarian cancer	0.00117	0.00226	CcSEcCtD
Etidronic acid—Agranulocytosis—Epirubicin—ovarian cancer	0.00116	0.00224	CcSEcCtD
Etidronic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.00114	0.00221	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00114	0.0022	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00114	0.00219	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00113	0.00218	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—NRAS—ovarian cancer	0.00112	0.0105	CbGpPWpGaD
Etidronic acid—Urticaria—Paclitaxel—ovarian cancer	0.0011	0.00213	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—DLC1—ovarian cancer	0.0011	0.0104	CbGpPWpGaD
Etidronic acid—Abdominal pain—Paclitaxel—ovarian cancer	0.0011	0.00212	CcSEcCtD
Etidronic acid—Agranulocytosis—Doxorubicin—ovarian cancer	0.00107	0.00207	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00107	0.00207	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAPK3—ovarian cancer	0.00107	0.0101	CbGpPWpGaD
Etidronic acid—Paraesthesia—Docetaxel—ovarian cancer	0.00106	0.00204	CcSEcCtD
Etidronic acid—Erythema multiforme—Epirubicin—ovarian cancer	0.00106	0.00204	CcSEcCtD
Etidronic acid—Dyspepsia—Docetaxel—ovarian cancer	0.00104	0.002	CcSEcCtD
Etidronic acid—Hypersensitivity—Paclitaxel—ovarian cancer	0.00102	0.00197	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—MAPK1—ovarian cancer	0.00102	0.00957	CbGpPWpGaD
Etidronic acid—Constipation—Docetaxel—ovarian cancer	0.00101	0.00194	CcSEcCtD
Etidronic acid—Alopecia—Epirubicin—ovarian cancer	0.000988	0.00191	CcSEcCtD
Etidronic acid—Pruritus—Paclitaxel—ovarian cancer	0.000983	0.0019	CcSEcCtD
Etidronic acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000978	0.00189	CcSEcCtD
Etidronic acid—Erythema—Epirubicin—ovarian cancer	0.000973	0.00188	CcSEcCtD
Etidronic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.00097	0.00187	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000963	0.00186	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KRAS—ovarian cancer	0.000961	0.00904	CbGpPWpGaD
Etidronic acid—Flatulence—Epirubicin—ovarian cancer	0.000959	0.00185	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PPP1CC—ovarian cancer	0.000953	0.00896	CbGpPWpGaD
Etidronic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.00095	0.00183	CcSEcCtD
Etidronic acid—Muscle spasms—Epirubicin—ovarian cancer	0.000935	0.0018	CcSEcCtD
Etidronic acid—Abdominal pain—Docetaxel—ovarian cancer	0.000931	0.0018	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000916	0.00862	CbGpPWpGaD
Etidronic acid—Alopecia—Doxorubicin—ovarian cancer	0.000914	0.00176	CcSEcCtD
Etidronic acid—Erythema—Doxorubicin—ovarian cancer	0.0009	0.00174	CcSEcCtD
Etidronic acid—Anaemia—Epirubicin—ovarian cancer	0.000899	0.00173	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—BCL9—ovarian cancer	0.000898	0.00844	CbGpPWpGaD
Etidronic acid—Flatulence—Doxorubicin—ovarian cancer	0.000887	0.00171	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000885	0.00832	CbGpPWpGaD
Etidronic acid—Vomiting—Paclitaxel—ovarian cancer	0.000883	0.0017	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—PIK3CA—ovarian cancer	0.000883	0.0083	CbGpPWpGaD
Etidronic acid—Rash—Paclitaxel—ovarian cancer	0.000876	0.00169	CcSEcCtD
Etidronic acid—Dermatitis—Paclitaxel—ovarian cancer	0.000875	0.00169	CcSEcCtD
Etidronic acid—Leukopenia—Epirubicin—ovarian cancer	0.000871	0.00168	CcSEcCtD
Etidronic acid—Headache—Paclitaxel—ovarian cancer	0.00087	0.00168	CcSEcCtD
Etidronic acid—Hypersensitivity—Docetaxel—ovarian cancer	0.000867	0.00167	CcSEcCtD
Etidronic acid—Muscle spasms—Doxorubicin—ovarian cancer	0.000865	0.00167	CcSEcCtD
Etidronic acid—Pruritus—Docetaxel—ovarian cancer	0.000833	0.00161	CcSEcCtD
Etidronic acid—Anaemia—Doxorubicin—ovarian cancer	0.000832	0.00161	CcSEcCtD
Etidronic acid—Arthralgia—Epirubicin—ovarian cancer	0.000828	0.0016	CcSEcCtD
Etidronic acid—Nausea—Paclitaxel—ovarian cancer	0.000825	0.00159	CcSEcCtD
Etidronic acid—Discomfort—Epirubicin—ovarian cancer	0.000818	0.00158	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—HRAS—ovarian cancer	0.000817	0.00768	CbGpPWpGaD
Etidronic acid—Leukopenia—Doxorubicin—ovarian cancer	0.000806	0.00155	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—ovarian cancer	0.000805	0.00155	CcSEcCtD
Etidronic acid—Confusional state—Epirubicin—ovarian cancer	0.000801	0.00154	CcSEcCtD
Etidronic acid—Infection—Epirubicin—ovarian cancer	0.000789	0.00152	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—ovarian cancer	0.000782	0.00735	CbGpPWpGaD
Etidronic acid—Arthralgia—Doxorubicin—ovarian cancer	0.000766	0.00148	CcSEcCtD
Etidronic acid—Discomfort—Doxorubicin—ovarian cancer	0.000757	0.00146	CcSEcCtD
Etidronic acid—Vomiting—Docetaxel—ovarian cancer	0.000748	0.00144	CcSEcCtD
Etidronic acid—Rash—Docetaxel—ovarian cancer	0.000742	0.00143	CcSEcCtD
Etidronic acid—Dermatitis—Docetaxel—ovarian cancer	0.000742	0.00143	CcSEcCtD
Etidronic acid—Confusional state—Doxorubicin—ovarian cancer	0.000741	0.00143	CcSEcCtD
Etidronic acid—Headache—Docetaxel—ovarian cancer	0.000737	0.00142	CcSEcCtD
Etidronic acid—Infection—Doxorubicin—ovarian cancer	0.00073	0.00141	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000723	0.0014	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—HDAC6—ovarian cancer	0.000722	0.00679	CbGpPWpGaD
Etidronic acid—Paraesthesia—Epirubicin—ovarian cancer	0.000713	0.00138	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—DOK1—ovarian cancer	0.00071	0.00667	CbGpPWpGaD
Etidronic acid—Nausea—Docetaxel—ovarian cancer	0.000699	0.00135	CcSEcCtD
Etidronic acid—Dyspepsia—Epirubicin—ovarian cancer	0.000699	0.00135	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000699	0.00657	CbGpPWpGaD
Etidronic acid—Constipation—Epirubicin—ovarian cancer	0.000679	0.00131	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000669	0.00129	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PPP1CC—ovarian cancer	0.000667	0.00627	CbGpPWpGaD
Etidronic acid—Paraesthesia—Doxorubicin—ovarian cancer	0.00066	0.00127	CcSEcCtD
Etidronic acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000654	0.00126	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000649	0.00125	CcSEcCtD
Etidronic acid—Dyspepsia—Doxorubicin—ovarian cancer	0.000647	0.00125	CcSEcCtD
Etidronic acid—Urticaria—Epirubicin—ovarian cancer	0.000631	0.00122	CcSEcCtD
Etidronic acid—Constipation—Doxorubicin—ovarian cancer	0.000628	0.00121	CcSEcCtD
Etidronic acid—Abdominal pain—Epirubicin—ovarian cancer	0.000628	0.00121	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—XIAP—ovarian cancer	0.000626	0.00589	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SMARCA4—ovarian cancer	0.00061	0.00574	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000605	0.00117	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000601	0.00116	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—EREG—ovarian cancer	0.000595	0.0056	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Epirubicin—ovarian cancer	0.000585	0.00113	CcSEcCtD
Etidronic acid—Urticaria—Doxorubicin—ovarian cancer	0.000584	0.00113	CcSEcCtD
Etidronic acid—Abdominal pain—Doxorubicin—ovarian cancer	0.000581	0.00112	CcSEcCtD
Etidronic acid—Pruritus—Epirubicin—ovarian cancer	0.000562	0.00108	CcSEcCtD
Etidronic acid—Diarrhoea—Epirubicin—ovarian cancer	0.000543	0.00105	CcSEcCtD
Etidronic acid—Hypersensitivity—Doxorubicin—ovarian cancer	0.000541	0.00104	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FASN—ovarian cancer	0.000521	0.0049	CbGpPWpGaD
Etidronic acid—Pruritus—Doxorubicin—ovarian cancer	0.00052	0.001	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PARP1—ovarian cancer	0.000519	0.00488	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HDAC6—ovarian cancer	0.000506	0.00475	CbGpPWpGaD
Etidronic acid—Vomiting—Epirubicin—ovarian cancer	0.000505	0.000974	CcSEcCtD
Etidronic acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000503	0.00097	CcSEcCtD
Etidronic acid—Rash—Epirubicin—ovarian cancer	0.000501	0.000966	CcSEcCtD
Etidronic acid—Dermatitis—Epirubicin—ovarian cancer	0.0005	0.000965	CcSEcCtD
Etidronic acid—Headache—Epirubicin—ovarian cancer	0.000497	0.00096	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—SLC2A1—ovarian cancer	0.000495	0.00465	CbGpPWpGaD
Etidronic acid—Nausea—Epirubicin—ovarian cancer	0.000472	0.00091	CcSEcCtD
Etidronic acid—Vomiting—Doxorubicin—ovarian cancer	0.000467	0.000901	CcSEcCtD
Etidronic acid—Rash—Doxorubicin—ovarian cancer	0.000463	0.000894	CcSEcCtD
Etidronic acid—Dermatitis—Doxorubicin—ovarian cancer	0.000463	0.000893	CcSEcCtD
Etidronic acid—Headache—Doxorubicin—ovarian cancer	0.00046	0.000888	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—YAP1—ovarian cancer	0.000447	0.00421	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—XIAP—ovarian cancer	0.000438	0.00412	CbGpPWpGaD
Etidronic acid—Nausea—Doxorubicin—ovarian cancer	0.000436	0.000842	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—SMARCA4—ovarian cancer	0.000427	0.00402	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PPP2R1A—ovarian cancer	0.000421	0.00396	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EREG—ovarian cancer	0.000417	0.00392	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PGR—ovarian cancer	0.000391	0.00367	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PARP1—ovarian cancer	0.000363	0.00342	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TERT—ovarian cancer	0.000334	0.00314	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CAV1—ovarian cancer	0.000309	0.00291	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PPP2R1A—ovarian cancer	0.000295	0.00277	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6ST—ovarian cancer	0.000293	0.00276	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—APC—ovarian cancer	0.000282	0.00265	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CD—ovarian cancer	0.000248	0.00233	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TERT—ovarian cancer	0.000234	0.0022	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ERBB2—ovarian cancer	0.000219	0.00206	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CAV1—ovarian cancer	0.000217	0.00204	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MTOR—ovarian cancer	0.000216	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CB—ovarian cancer	0.000216	0.00203	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—ovarian cancer	0.000209	0.00196	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6ST—ovarian cancer	0.000205	0.00193	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CDKN1B—ovarian cancer	0.000203	0.0019	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—APC—ovarian cancer	0.000197	0.00185	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CG—ovarian cancer	0.000197	0.00185	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—CTNNB1—ovarian cancer	0.000191	0.0018	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PTEN—ovarian cancer	0.000186	0.00175	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CD—ovarian cancer	0.000173	0.00163	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—STAT3—ovarian cancer	0.000167	0.00157	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—NRAS—ovarian cancer	0.000166	0.00156	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK3—ovarian cancer	0.000159	0.0015	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—ovarian cancer	0.000155	0.00146	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ERBB2—ovarian cancer	0.000153	0.00144	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MAPK1—ovarian cancer	0.000152	0.00143	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—EGFR—ovarian cancer	0.000152	0.00143	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CB—ovarian cancer	0.000151	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MTOR—ovarian cancer	0.000151	0.00142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CXCL8—ovarian cancer	0.000145	0.00137	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—KRAS—ovarian cancer	0.000143	0.00135	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CDKN1B—ovarian cancer	0.000142	0.00133	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CASP3—ovarian cancer	0.000139	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL2—ovarian cancer	0.000139	0.00131	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CCND1—ovarian cancer	0.000135	0.00127	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CTNNB1—ovarian cancer	0.000134	0.00126	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PIK3CA—ovarian cancer	0.000132	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MMP9—ovarian cancer	0.000131	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTEN—ovarian cancer	0.000131	0.00123	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—HRAS—ovarian cancer	0.000122	0.00114	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—VEGFA—ovarian cancer	0.000118	0.00111	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—STAT3—ovarian cancer	0.000117	0.0011	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—NRAS—ovarian cancer	0.000116	0.0011	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—ovarian cancer	0.000116	0.0011	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK3—ovarian cancer	0.000112	0.00105	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—ovarian cancer	0.000109	0.00102	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—AKT1—ovarian cancer	0.000107	0.00101	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MAPK1—ovarian cancer	0.000106	0.000998	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—EGFR—ovarian cancer	0.000106	0.000998	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KRAS—ovarian cancer	0.0001	0.000943	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PIK3CA—ovarian cancer	9.21e-05	0.000866	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TP53—ovarian cancer	8.91e-05	0.000838	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—HRAS—ovarian cancer	8.52e-05	0.000801	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—ovarian cancer	8.16e-05	0.000767	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—AKT1—ovarian cancer	7.53e-05	0.000708	CbGpPWpGaD
